

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.32035586 |
| 2 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.90495689 |
| 3 | positive regulation of interferon-alpha production (GO:0032727) | 5.47496020 |
| 4 | protein maturation by protein folding (GO:0022417) | 5.35608184 |
| 5 | regulation of interferon-alpha production (GO:0032647) | 5.22194804 |
| 6 | cellular response to virus (GO:0098586) | 5.03843071 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.96666486 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.96666486 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.96666486 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.96666486 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.96666486 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.96666486 |
| 13 | proteasome assembly (GO:0043248) | 4.74395982 |
| 14 | regulation of mononuclear cell migration (GO:0071675) | 4.72813214 |
| 15 | positive regulation of actin filament depolymerization (GO:0030836) | 4.65591753 |
| 16 | lymphocyte chemotaxis (GO:0048247) | 4.49973628 |
| 17 | Golgi transport vesicle coating (GO:0048200) | 4.49920801 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 4.49920801 |
| 19 | actin filament depolymerization (GO:0030042) | 4.44458354 |
| 20 | type B pancreatic cell proliferation (GO:0044342) | 4.42237505 |
| 21 | positive regulation of pseudopodium assembly (GO:0031274) | 4.40378076 |
| 22 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.26343761 |
| 23 | extracellular fibril organization (GO:0043206) | 4.23555664 |
| 24 | eosinophil migration (GO:0072677) | 4.22488316 |
| 25 | lipopolysaccharide biosynthetic process (GO:0009103) | 4.13668883 |
| 26 | barbed-end actin filament capping (GO:0051016) | 4.13238368 |
| 27 | skin morphogenesis (GO:0043589) | 4.06205627 |
| 28 | macrophage chemotaxis (GO:0048246) | 4.04510456 |
| 29 | response to type I interferon (GO:0034340) | 4.03065010 |
| 30 | regulation of RIG-I signaling pathway (GO:0039535) | 3.98736362 |
| 31 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.95391368 |
| 32 | regulation of pseudopodium assembly (GO:0031272) | 3.91370207 |
| 33 | muscle cell migration (GO:0014812) | 3.91364616 |
| 34 | fibril organization (GO:0097435) | 3.89676289 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.88303460 |
| 36 | hepatocyte apoptotic process (GO:0097284) | 3.86460329 |
| 37 | membrane raft organization (GO:0031579) | 3.85178347 |
| 38 | protein retention in ER lumen (GO:0006621) | 3.84077122 |
| 39 | cellular response to type I interferon (GO:0071357) | 3.83627542 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.83627542 |
| 41 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.80072639 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.75121865 |
| 43 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.74459778 |
| 44 | virion attachment to host cell (GO:0019062) | 3.73930217 |
| 45 | adhesion of symbiont to host cell (GO:0044650) | 3.73930217 |
| 46 | positive regulation of interferon-beta production (GO:0032728) | 3.73664819 |
| 47 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.68783480 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.67851621 |
| 49 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.56392220 |
| 50 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.52630954 |
| 51 | endothelial tube morphogenesis (GO:0061154) | 3.51114646 |
| 52 | morphogenesis of an endothelium (GO:0003159) | 3.51114646 |
| 53 | desmosome organization (GO:0002934) | 3.50008384 |
| 54 | lipopolysaccharide metabolic process (GO:0008653) | 3.47934325 |
| 55 | cellular response to interferon-alpha (GO:0035457) | 3.47627453 |
| 56 | regulation of interleukin-1 secretion (GO:0050704) | 3.44627253 |
| 57 | cellular response to zinc ion (GO:0071294) | 3.42542235 |
| 58 | negative regulation of viral genome replication (GO:0045071) | 3.41645562 |
| 59 | regulation of viral entry into host cell (GO:0046596) | 3.36848060 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36836496 |
| 61 | response to peptidoglycan (GO:0032494) | 3.36596692 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33181007 |
| 63 | response to host immune response (GO:0052572) | 3.33181007 |
| 64 | GDP-mannose metabolic process (GO:0019673) | 3.30920602 |
| 65 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.30535146 |
| 66 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.29537138 |
| 67 | negative regulation of viral entry into host cell (GO:0046597) | 3.28281321 |
| 68 | nuclear envelope reassembly (GO:0031468) | 3.24356690 |
| 69 | mitotic nuclear envelope reassembly (GO:0007084) | 3.24356690 |
| 70 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.24234358 |
| 71 | regulation of respiratory burst (GO:0060263) | 3.24066604 |
| 72 | regulation of interferon-beta production (GO:0032648) | 3.21935759 |
| 73 | intestinal epithelial cell development (GO:0060576) | 3.19847003 |
| 74 | chondrocyte proliferation (GO:0035988) | 3.19453709 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.18973798 |
| 76 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.18364006 |
| 77 | diol metabolic process (GO:0034311) | 3.16525125 |
| 78 | positive regulation of interleukin-1 production (GO:0032732) | 3.16147736 |
| 79 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.15011111 |
| 80 | cellular response to exogenous dsRNA (GO:0071360) | 3.14305434 |
| 81 | renal system process involved in regulation of blood volume (GO:0001977) | 3.14267410 |
| 82 | response to interferon-alpha (GO:0035455) | 3.12781985 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11213911 |
| 84 | response to host (GO:0075136) | 3.11213911 |
| 85 | response to host defenses (GO:0052200) | 3.11213911 |
| 86 | regulation of viral release from host cell (GO:1902186) | 3.10970372 |
| 87 | oligosaccharide biosynthetic process (GO:0009312) | 3.10214214 |
| 88 | epithelial structure maintenance (GO:0010669) | 3.09357633 |
| 89 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.08845327 |
| 90 | cellular copper ion homeostasis (GO:0006878) | 3.06582569 |
| 91 | establishment of viral latency (GO:0019043) | 3.06083778 |
| 92 | adhesion of symbiont to host (GO:0044406) | 3.04244010 |
| 93 | cytidine metabolic process (GO:0046087) | 3.03977685 |
| 94 | cytidine catabolic process (GO:0006216) | 3.03977685 |
| 95 | cytidine deamination (GO:0009972) | 3.03977685 |
| 96 | cellular extravasation (GO:0045123) | 3.03624873 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.02766338 |
| 98 | macrophage activation involved in immune response (GO:0002281) | 3.02764117 |
| 99 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.98860807 |
| 100 | regulation of extracellular matrix disassembly (GO:0010715) | 2.96799085 |
| 101 | striated muscle atrophy (GO:0014891) | 2.95532927 |
| 102 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94926194 |
| 103 | intestinal absorption (GO:0050892) | 2.94608022 |
| 104 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.94598656 |
| 105 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.90790009 |
| 106 | nucleotide transmembrane transport (GO:1901679) | 2.90776990 |
| 107 | fibrinolysis (GO:0042730) | 2.89825608 |
| 108 | monocyte chemotaxis (GO:0002548) | 2.88724495 |
| 109 | B cell mediated immunity (GO:0019724) | 2.88679112 |
| 110 | galactose metabolic process (GO:0006012) | 2.88164322 |
| 111 | regulation of protein glycosylation (GO:0060049) | 2.87943214 |
| 112 | neutrophil chemotaxis (GO:0030593) | 2.86674150 |
| 113 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.85823941 |
| 114 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.84547153 |
| 115 | thrombin receptor signaling pathway (GO:0070493) | 2.83388887 |
| 116 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.83379363 |
| 117 | regulation of metalloenzyme activity (GO:0048552) | 2.83180987 |
| 118 | regulation of podosome assembly (GO:0071801) | 2.83028682 |
| 119 | neutrophil migration (GO:1990266) | 2.82850003 |
| 120 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.82537550 |
| 121 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.81999545 |
| 122 | regulation of defense response to virus by host (GO:0050691) | 2.81771535 |
| 123 | positive regulation of response to cytokine stimulus (GO:0060760) | 2.81760746 |
| 124 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.81731877 |
| 125 | regulation of guanylate cyclase activity (GO:0031282) | 2.81690170 |
| 126 | regulation of integrin activation (GO:0033623) | 2.80253565 |
| 127 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.79844876 |
| 128 | eosinophil chemotaxis (GO:0048245) | 2.78997570 |
| 129 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.77163858 |
| 130 | response to interferon-beta (GO:0035456) | 2.75652605 |
| 131 | cellular response to interferon-beta (GO:0035458) | 2.74934021 |
| 132 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.73397397 |
| 133 | regulation of vitamin metabolic process (GO:0030656) | 2.72262261 |
| 134 | negative regulation of defense response to virus (GO:0050687) | 2.71736310 |
| 135 | endocardial cushion development (GO:0003197) | 2.68816992 |
| 136 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.68074617 |
| 137 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.67839988 |
| 138 | glomerular visceral epithelial cell development (GO:0072015) | 2.67427639 |
| 139 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.66066515 |
| 140 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.66037327 |
| 141 | cell adhesion mediated by integrin (GO:0033627) | 2.65215530 |
| 142 | cellular response to interferon-gamma (GO:0071346) | 2.65188186 |
| 143 | positive regulation of type 2 immune response (GO:0002830) | 2.64259808 |
| 144 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.63669904 |
| 145 | negative regulation of viral process (GO:0048525) | 2.63148858 |
| 146 | actin nucleation (GO:0045010) | 2.61584360 |
| 147 | protein localization to endosome (GO:0036010) | 2.61322337 |
| 148 | granulocyte activation (GO:0036230) | 2.60755436 |
| 149 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.60091817 |
| 150 | natural killer cell mediated immunity (GO:0002228) | 2.60091817 |
| 151 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.59330570 |
| 152 | establishment of integrated proviral latency (GO:0075713) | 2.59013703 |
| 153 | response to copper ion (GO:0046688) | 2.58016235 |
| 154 | ventricular cardiac muscle cell development (GO:0055015) | 2.57838928 |
| 155 | angiotensin maturation (GO:0002003) | 2.56398317 |
| 156 | sulfate transmembrane transport (GO:1902358) | 2.56052519 |
| 157 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.55984771 |
| 158 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.55984771 |
| 159 | T-helper 1 type immune response (GO:0042088) | 2.55930549 |
| 160 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.55514001 |
| 161 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.55499114 |
| 162 | positive regulation of interleukin-6 production (GO:0032755) | 2.55291257 |
| 163 | substrate-dependent cell migration (GO:0006929) | 2.54635346 |
| 164 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.53899049 |
| 165 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53879327 |
| 166 | NADH metabolic process (GO:0006734) | 2.53832227 |
| 167 | cellular response to cadmium ion (GO:0071276) | 2.53640938 |
| 168 | lymphocyte migration (GO:0072676) | 2.53596369 |
| 169 | galactose catabolic process (GO:0019388) | 2.53029122 |
| 170 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.51382696 |
| 171 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.51006402 |
| 172 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.50334388 |
| 173 | protein hydroxylation (GO:0018126) | 2.49922933 |
| 174 | glucuronate metabolic process (GO:0019585) | 2.46599571 |
| 175 | uronic acid metabolic process (GO:0006063) | 2.46599571 |
| 176 | membrane budding (GO:0006900) | 2.46090715 |
| 177 | cellular glucuronidation (GO:0052695) | 2.45699260 |
| 178 | decidualization (GO:0046697) | 2.44627110 |
| 179 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.42527177 |
| 180 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.42491609 |
| 181 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.41735576 |
| 182 | negative regulation of ligase activity (GO:0051352) | 2.40603240 |
| 183 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.40603240 |
| 184 | cellular response to pH (GO:0071467) | 2.40147895 |
| 185 | regulation of actin filament depolymerization (GO:0030834) | 2.39697960 |
| 186 | regulation of cellular extravasation (GO:0002691) | 2.39177044 |
| 187 | regulation of interleukin-8 secretion (GO:2000482) | 2.38704783 |
| 188 | negative regulation of protein autophosphorylation (GO:0031953) | 2.38008099 |
| 189 | hyaluronan catabolic process (GO:0030214) | 2.37890886 |
| 190 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.36805989 |
| 191 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.36693479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.45900821 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.99304311 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.84640645 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81924839 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.13938172 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.70497043 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.92312227 |
| 8 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.91861115 |
| 9 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.78438677 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63414970 |
| 11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.62322271 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.46775476 |
| 13 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.45286512 |
| 14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.43566443 |
| 15 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.39623431 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35365124 |
| 17 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.31945929 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.31563478 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28739055 |
| 20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.21059989 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20403454 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.20076039 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.18665229 |
| 24 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.17886512 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.08914480 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99699347 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.97706371 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.96347350 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.94403196 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94304491 |
| 31 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.88649921 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88013777 |
| 33 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.84011663 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79134368 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.77556614 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77545668 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73613592 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71274397 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69977751 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66490662 |
| 41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.63999470 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.63557978 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60450041 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.57785442 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55942148 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.50521209 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47747605 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46649670 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46456384 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44964440 |
| 51 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.43792457 |
| 52 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43229237 |
| 53 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40075486 |
| 54 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39073719 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37381754 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36909413 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35946021 |
| 58 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35233558 |
| 59 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35029111 |
| 60 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35029111 |
| 61 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33672467 |
| 62 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.33137013 |
| 63 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30950765 |
| 64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.30810384 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28685715 |
| 66 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28333368 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27101892 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26685973 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26318997 |
| 70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.25071751 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24439664 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23589775 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23174601 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21717552 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21044137 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.20488692 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20268805 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19779309 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19359131 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18939158 |
| 81 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.18430881 |
| 82 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.17854166 |
| 83 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17813322 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17553859 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17162366 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15120752 |
| 87 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.13660561 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12953549 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12509603 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11100047 |
| 91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10553931 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10344124 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09648692 |
| 94 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09519310 |
| 95 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09510066 |
| 96 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09381035 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08721996 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07911430 |
| 99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06620094 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05992829 |
| 101 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04857840 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04830010 |
| 103 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04701841 |
| 104 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03596020 |
| 105 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.02569331 |
| 106 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02470683 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02314041 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02190320 |
| 109 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01836492 |
| 110 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98727635 |
| 111 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98592973 |
| 112 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98556528 |
| 113 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98507082 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97726442 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97339558 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96094143 |
| 117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95359564 |
| 118 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.95009738 |
| 119 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94768694 |
| 120 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94599102 |
| 121 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.94404576 |
| 122 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94396296 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94393140 |
| 124 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94292322 |
| 125 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93980138 |
| 126 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92122562 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92094321 |
| 128 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91066611 |
| 129 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90898066 |
| 130 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90301202 |
| 131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90257220 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89743585 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87830996 |
| 134 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.86084420 |
| 135 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.85296317 |
| 136 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.85258870 |
| 137 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83505678 |
| 138 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83230723 |
| 139 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.82222083 |
| 140 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81018428 |
| 141 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.80661275 |
| 142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79830364 |
| 143 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.79328333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.21864509 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.04297734 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.69288347 |
| 4 | MP0009840_abnormal_foam_cell | 3.07231935 |
| 5 | MP0006082_CNS_inflammation | 2.94421394 |
| 6 | MP0009785_altered_susceptibility_to | 2.92768752 |
| 7 | MP0004272_abnormal_basement_membrane | 2.87780802 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.51782468 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.46919966 |
| 10 | MP0000462_abnormal_digestive_system | 2.43652605 |
| 11 | MP0010155_abnormal_intestine_physiology | 2.42484690 |
| 12 | MP0010030_abnormal_orbit_morphology | 2.40287769 |
| 13 | MP0000490_abnormal_crypts_of | 2.39499006 |
| 14 | MP0003436_decreased_susceptibility_to | 2.38205494 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.37430454 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.32809395 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.31033187 |
| 18 | MP0005670_abnormal_white_adipose | 2.28000486 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.25656867 |
| 20 | MP0001542_abnormal_bone_strength | 2.13218316 |
| 21 | MP0010368_abnormal_lymphatic_system | 2.11152910 |
| 22 | MP0003303_peritoneal_inflammation | 2.09843055 |
| 23 | MP0003866_abnormal_defecation | 2.08620617 |
| 24 | MP0005025_abnormal_response_to | 2.08310530 |
| 25 | MP0008004_abnormal_stomach_pH | 2.07206873 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.06069006 |
| 27 | MP0005310_abnormal_salivary_gland | 2.05209851 |
| 28 | MP0003315_abnormal_perineum_morphology | 2.03240073 |
| 29 | MP0005275_abnormal_skin_tensile | 2.02107463 |
| 30 | MP0004947_skin_inflammation | 2.00712484 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.97469530 |
| 32 | MP0005165_increased_susceptibility_to | 1.92389070 |
| 33 | MP0001663_abnormal_digestive_system | 1.90347492 |
| 34 | MP0005381_digestive/alimentary_phenotyp | 1.89472518 |
| 35 | MP0002102_abnormal_ear_morphology | 1.89379817 |
| 36 | MP0003724_increased_susceptibility_to | 1.87029548 |
| 37 | MP0001873_stomach_inflammation | 1.85177435 |
| 38 | MP0006054_spinal_hemorrhage | 1.83663105 |
| 39 | MP0003279_aneurysm | 1.81160177 |
| 40 | MP0005360_urolithiasis | 1.79949263 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.79080587 |
| 42 | MP0002419_abnormal_innate_immunity | 1.78119095 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.77994794 |
| 44 | MP0004043_abnormal_pH_regulation | 1.77232181 |
| 45 | MP0004264_abnormal_extraembryonic_tissu | 1.77178420 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.76189019 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.66173475 |
| 48 | MP0001958_emphysema | 1.64809245 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.62567543 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.61297231 |
| 51 | MP0005377_hearing/vestibular/ear_phenot | 1.60958686 |
| 52 | MP0003878_abnormal_ear_physiology | 1.60958686 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.60302134 |
| 54 | MP0004510_myositis | 1.57768828 |
| 55 | MP0001790_abnormal_immune_system | 1.54477822 |
| 56 | MP0005387_immune_system_phenotype | 1.54477822 |
| 57 | MP0003283_abnormal_digestive_organ | 1.50726568 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.50634352 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.50340746 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.49363451 |
| 61 | MP0002060_abnormal_skin_morphology | 1.45015249 |
| 62 | MP0000751_myopathy | 1.43545434 |
| 63 | MP0000604_amyloidosis | 1.43011637 |
| 64 | MP0010678_abnormal_skin_adnexa | 1.41822595 |
| 65 | MP0000343_altered_response_to | 1.40628574 |
| 66 | MP0005197_abnormal_uvea_morphology | 1.37217519 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.36940699 |
| 68 | MP0000749_muscle_degeneration | 1.36772170 |
| 69 | MP0000477_abnormal_intestine_morphology | 1.35112324 |
| 70 | MP0002723_abnormal_immune_serum | 1.33594467 |
| 71 | MP0001666_abnormal_nutrient_absorption | 1.33027707 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.32821961 |
| 73 | MP0000685_abnormal_immune_system | 1.32684091 |
| 74 | MP0005330_cardiomyopathy | 1.31053319 |
| 75 | MP0005451_abnormal_body_composition | 1.30849836 |
| 76 | MP0005501_abnormal_skin_physiology | 1.30447658 |
| 77 | MP0002822_catalepsy | 1.28859994 |
| 78 | MP0001800_abnormal_humoral_immune | 1.27635201 |
| 79 | MP0001243_abnormal_dermal_layer | 1.25707074 |
| 80 | MP0001881_abnormal_mammary_gland | 1.24920431 |
| 81 | MP0003091_abnormal_cell_migration | 1.23360350 |
| 82 | MP0001819_abnormal_immune_cell | 1.21424189 |
| 83 | MP0002896_abnormal_bone_mineralization | 1.20937793 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.20099258 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.20059757 |
| 86 | MP0008469_abnormal_protein_level | 1.18917874 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.18629224 |
| 88 | MP0000762_abnormal_tongue_morphology | 1.15780007 |
| 89 | MP0005395_other_phenotype | 1.15643248 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.15410009 |
| 91 | MP0003718_maternal_effect | 1.15273901 |
| 92 | MP0005408_hypopigmentation | 1.14435677 |
| 93 | MP0003186_abnormal_redox_activity | 1.13832126 |
| 94 | MP0005671_abnormal_response_to | 1.12100996 |
| 95 | MP0009764_decreased_sensitivity_to | 1.10864947 |
| 96 | MP0000538_abnormal_urinary_bladder | 1.10706947 |
| 97 | MP0002006_tumorigenesis | 1.10279908 |
| 98 | MP0005166_decreased_susceptibility_to | 1.08729744 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 1.08347926 |
| 100 | MP0008775_abnormal_heart_ventricle | 1.08290242 |
| 101 | MP0008260_abnormal_autophagy | 1.05836179 |
| 102 | MP0005023_abnormal_wound_healing | 1.05387374 |
| 103 | MP0002136_abnormal_kidney_physiology | 1.03309431 |
| 104 | MP0004858_abnormal_nervous_system | 1.02366885 |
| 105 | MP0005365_abnormal_bile_salt | 1.01682533 |
| 106 | MP0003448_altered_tumor_morphology | 1.01605662 |
| 107 | MP0002405_respiratory_system_inflammati | 1.00405197 |
| 108 | MP0001853_heart_inflammation | 0.97666623 |
| 109 | MP0002796_impaired_skin_barrier | 0.95039341 |
| 110 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94842111 |
| 111 | MP0009379_abnormal_foot_pigmentation | 0.94527643 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.92840320 |
| 113 | MP0005257_abnormal_intraocular_pressure | 0.92553226 |
| 114 | MP0000750_abnormal_muscle_regeneration | 0.90917345 |
| 115 | MP0005508_abnormal_skeleton_morphology | 0.90226119 |
| 116 | MP0004147_increased_porphyrin_level | 0.89610515 |
| 117 | MP0003075_altered_response_to | 0.89035942 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.88981076 |
| 119 | MP0003941_abnormal_skin_development | 0.88376040 |
| 120 | MP0003646_muscle_fatigue | 0.87870019 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.86596508 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.86559156 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.84729987 |
| 124 | MP0005503_abnormal_tendon_morphology | 0.83158788 |
| 125 | MP0005367_renal/urinary_system_phenotyp | 0.81808604 |
| 126 | MP0000516_abnormal_urinary_system | 0.81808604 |
| 127 | MP0000627_abnormal_mammary_gland | 0.81325803 |
| 128 | MP0000858_altered_metastatic_potential | 0.81306343 |
| 129 | MP0001849_ear_inflammation | 0.81176684 |
| 130 | MP0005164_abnormal_response_to | 0.80826110 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.80781695 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.80647773 |
| 133 | MP0002295_abnormal_pulmonary_circulatio | 0.79912284 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.78971254 |
| 135 | MP0005076_abnormal_cell_differentiation | 0.78413650 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.76630315 |
| 137 | MP0001756_abnormal_urination | 0.76332989 |
| 138 | MP0000383_abnormal_hair_follicle | 0.76030304 |
| 139 | MP0005171_absent_coat_pigmentation | 0.75673715 |
| 140 | MP0001664_abnormal_digestion | 0.74103527 |
| 141 | MP0002138_abnormal_hepatobiliary_system | 0.74035128 |
| 142 | MP0010307_abnormal_tumor_latency | 0.73730960 |
| 143 | MP0000470_abnormal_stomach_morphology | 0.73612862 |
| 144 | MP0005083_abnormal_biliary_tract | 0.73417313 |
| 145 | MP0000537_abnormal_urethra_morphology | 0.73230578 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.72877078 |
| 147 | MP0003252_abnormal_bile_duct | 0.72683332 |
| 148 | MP0004019_abnormal_vitamin_homeostasis | 0.72422530 |
| 149 | MP0000681_abnormal_thyroid_gland | 0.70849648 |
| 150 | MP0002168_other_aberrant_phenotype | 0.70043088 |
| 151 | MP0000767_abnormal_smooth_muscle | 0.70039593 |
| 152 | MP0009278_abnormal_bone_marrow | 0.70032030 |
| 153 | MP0005390_skeleton_phenotype | 0.69780470 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.69567429 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68890116 |
| 156 | MP0002177_abnormal_outer_ear | 0.68532860 |
| 157 | MP0003868_abnormal_feces_composition | 0.67701044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.33238138 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.84258019 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.73954658 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.70317503 |
| 5 | Pustule (HP:0200039) | 4.37790191 |
| 6 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 4.16219319 |
| 7 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.01380129 |
| 8 | Ileus (HP:0002595) | 3.99403169 |
| 9 | Cupped ribs (HP:0000887) | 3.91094236 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.77927748 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.71098676 |
| 12 | Follicular hyperkeratosis (HP:0007502) | 3.66257070 |
| 13 | Villous atrophy (HP:0011473) | 3.63420722 |
| 14 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.63420722 |
| 15 | Prostate neoplasm (HP:0100787) | 3.61496391 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.60815543 |
| 17 | Cardiovascular calcification (HP:0011915) | 3.45707948 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.44744431 |
| 19 | Protrusio acetabuli (HP:0003179) | 3.43534065 |
| 20 | Vascular calcification (HP:0004934) | 3.37244229 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.29409426 |
| 22 | Cervical subluxation (HP:0003308) | 3.26784942 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.22064286 |
| 24 | Hyperactive renin-angiotensin system (HP:0000841) | 3.21294100 |
| 25 | Male infertility (HP:0003251) | 3.19359303 |
| 26 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.16447427 |
| 27 | Flat acetabular roof (HP:0003180) | 3.15327435 |
| 28 | Congenital sensorineural hearing impairment (HP:0008527) | 3.14866427 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.06432835 |
| 30 | Metabolic alkalosis (HP:0200114) | 3.03225775 |
| 31 | Abnormality of chloride homeostasis (HP:0011422) | 3.02892637 |
| 32 | Axonal loss (HP:0003447) | 3.01013883 |
| 33 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.99664863 |
| 34 | Intrahepatic cholestasis (HP:0001406) | 2.94814400 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89726602 |
| 36 | Glucose intolerance (HP:0000833) | 2.88266461 |
| 37 | Orchitis (HP:0100796) | 2.83530935 |
| 38 | Atrophic scars (HP:0001075) | 2.77713351 |
| 39 | Short nail (HP:0001799) | 2.73300132 |
| 40 | Pili torti (HP:0003777) | 2.71600384 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.70912338 |
| 42 | Recurrent skin infections (HP:0001581) | 2.70633330 |
| 43 | Entropion (HP:0000621) | 2.68044160 |
| 44 | Rough bone trabeculation (HP:0100670) | 2.67360173 |
| 45 | Esophageal varix (HP:0002040) | 2.64792809 |
| 46 | Right ventricular cardiomyopathy (HP:0011663) | 2.64523663 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.63294453 |
| 48 | Micronodular cirrhosis (HP:0001413) | 2.60418653 |
| 49 | Spinal cord compression (HP:0002176) | 2.57924001 |
| 50 | Myositis (HP:0100614) | 2.57278296 |
| 51 | Hypokinesia (HP:0002375) | 2.53560591 |
| 52 | Abdominal distention (HP:0003270) | 2.49152539 |
| 53 | Sensorimotor neuropathy (HP:0007141) | 2.48309010 |
| 54 | Gingivitis (HP:0000230) | 2.46803430 |
| 55 | Tongue fasciculations (HP:0001308) | 2.45763562 |
| 56 | Ankle contracture (HP:0006466) | 2.45685079 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.45224964 |
| 58 | Amyloidosis (HP:0011034) | 2.45097580 |
| 59 | Gastrointestinal dysmotility (HP:0002579) | 2.44211078 |
| 60 | Neonatal short-limb short stature (HP:0008921) | 2.43858709 |
| 61 | Periodontitis (HP:0000704) | 2.43746681 |
| 62 | Nausea (HP:0002018) | 2.43715027 |
| 63 | Abnormality of the costochondral junction (HP:0000919) | 2.42721807 |
| 64 | Optic neuritis (HP:0100653) | 2.40319015 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.40319015 |
| 66 | Ventricular fibrillation (HP:0001663) | 2.39825526 |
| 67 | Distal lower limb muscle weakness (HP:0009053) | 2.39656541 |
| 68 | Adrenal hypoplasia (HP:0000835) | 2.39498675 |
| 69 | Abnormal tarsal ossification (HP:0008369) | 2.39422106 |
| 70 | Spinal rigidity (HP:0003306) | 2.38029190 |
| 71 | Alopecia of scalp (HP:0002293) | 2.36622959 |
| 72 | Disinhibition (HP:0000734) | 2.35327339 |
| 73 | Microglossia (HP:0000171) | 2.35135760 |
| 74 | Septate vagina (HP:0001153) | 2.35039682 |
| 75 | Abnormality of the 1st metacarpal (HP:0010009) | 2.34951957 |
| 76 | Wormian bones (HP:0002645) | 2.34519910 |
| 77 | Ureteral stenosis (HP:0000071) | 2.34124728 |
| 78 | Glomerulonephritis (HP:0000099) | 2.33536432 |
| 79 | Cholecystitis (HP:0001082) | 2.33180717 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.33180717 |
| 81 | Distal upper limb amyotrophy (HP:0007149) | 2.32071106 |
| 82 | Upper limb amyotrophy (HP:0009129) | 2.32071106 |
| 83 | Hydroxyprolinuria (HP:0003080) | 2.31708577 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.31708577 |
| 85 | Petechiae (HP:0000967) | 2.31533176 |
| 86 | Abnormal glucose tolerance (HP:0001952) | 2.29520569 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.29382846 |
| 88 | Abnormal trabecular bone morphology (HP:0100671) | 2.28442243 |
| 89 | Sparse eyelashes (HP:0000653) | 2.28285316 |
| 90 | Cheilitis (HP:0100825) | 2.26604938 |
| 91 | Polycythemia (HP:0001901) | 2.26450371 |
| 92 | Muscle fibrillation (HP:0010546) | 2.25269256 |
| 93 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25037154 |
| 94 | Upper limb muscle weakness (HP:0003484) | 2.24887415 |
| 95 | Increased connective tissue (HP:0009025) | 2.23000239 |
| 96 | Breech presentation (HP:0001623) | 2.22555113 |
| 97 | Rectal prolapse (HP:0002035) | 2.21799032 |
| 98 | Abnormality of carpal bone ossification (HP:0006257) | 2.21352348 |
| 99 | Ureteral obstruction (HP:0006000) | 2.19576837 |
| 100 | Abnormality of glycolysis (HP:0004366) | 2.19334917 |
| 101 | Flat capital femoral epiphysis (HP:0003370) | 2.19235251 |
| 102 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.19076012 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 2.18431125 |
| 104 | Abnormality of the umbilical cord (HP:0010881) | 2.16498036 |
| 105 | Mediastinal lymphadenopathy (HP:0100721) | 2.14657125 |
| 106 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11861768 |
| 107 | Focal segmental glomerulosclerosis (HP:0000097) | 2.09918062 |
| 108 | Hand muscle atrophy (HP:0009130) | 2.08967585 |
| 109 | Arterial tortuosity (HP:0005116) | 2.08171987 |
| 110 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.07613694 |
| 111 | Abnormal hair laboratory examination (HP:0003328) | 2.07564718 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07533257 |
| 113 | Alkalosis (HP:0001948) | 2.07424154 |
| 114 | Metaphyseal cupping (HP:0003021) | 2.06336494 |
| 115 | Premature loss of primary teeth (HP:0006323) | 2.05967353 |
| 116 | Fat malabsorption (HP:0002630) | 2.03920116 |
| 117 | Cone-rod dystrophy (HP:0000548) | 2.03747942 |
| 118 | Basal ganglia calcification (HP:0002135) | 2.03684212 |
| 119 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.02620438 |
| 120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02322218 |
| 121 | Insulin resistance (HP:0000855) | 2.02264038 |
| 122 | Ovoid vertebral bodies (HP:0003300) | 2.02085079 |
| 123 | Multiple lipomas (HP:0001012) | 2.01809480 |
| 124 | Recurrent fungal infections (HP:0002841) | 2.00297428 |
| 125 | Tetany (HP:0001281) | 1.99197658 |
| 126 | Type I transferrin isoform profile (HP:0003642) | 1.99083838 |
| 127 | Abnormality of renin-angiotensin system (HP:0000847) | 1.98255880 |
| 128 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98137946 |
| 129 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98137946 |
| 130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98137946 |
| 131 | Blue sclerae (HP:0000592) | 1.96119325 |
| 132 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.95703987 |
| 133 | Progressive hearing impairment (HP:0001730) | 1.95473113 |
| 134 | Decreased circulating renin level (HP:0003351) | 1.95378285 |
| 135 | Nephritis (HP:0000123) | 1.94432512 |
| 136 | Generalized amyotrophy (HP:0003700) | 1.93120552 |
| 137 | Elbow flexion contracture (HP:0002987) | 1.91373347 |
| 138 | Anorexia (HP:0002039) | 1.90356292 |
| 139 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87292930 |
| 140 | Mucopolysacchariduria (HP:0008155) | 1.87292930 |
| 141 | Myocardial infarction (HP:0001658) | 1.87104345 |
| 142 | Thick nail (HP:0001805) | 1.86665304 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.85716140 |
| 144 | Natal tooth (HP:0000695) | 1.84180340 |
| 145 | Hyperparathyroidism (HP:0000843) | 1.83909961 |
| 146 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83868199 |
| 147 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83868199 |
| 148 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83868199 |
| 149 | Flattened epiphyses (HP:0003071) | 1.83775212 |
| 150 | Coxa vara (HP:0002812) | 1.83640623 |
| 151 | Malnutrition (HP:0004395) | 1.82730470 |
| 152 | Patchy hypopigmentation of hair (HP:0011365) | 1.82103519 |
| 153 | Abnormal ossification of hand bones (HP:0005921) | 1.82013229 |
| 154 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.81255375 |
| 155 | Muscle stiffness (HP:0003552) | 1.81231432 |
| 156 | Delayed CNS myelination (HP:0002188) | 1.81191046 |
| 157 | Hyponatremia (HP:0002902) | 1.80561315 |
| 158 | Overlapping toe (HP:0001845) | 1.79916819 |
| 159 | Vascular tortuosity (HP:0004948) | 1.79364549 |
| 160 | Abnormal delivery (HP:0001787) | 1.78876150 |
| 161 | Colitis (HP:0002583) | 1.78246918 |
| 162 | Vasculitis (HP:0002633) | 1.77933538 |
| 163 | Amniotic constriction ring (HP:0009775) | 1.77004287 |
| 164 | Abnormality of placental membranes (HP:0011409) | 1.77004287 |
| 165 | White forelock (HP:0002211) | 1.76710442 |
| 166 | Pulmonary fibrosis (HP:0002206) | 1.76596520 |
| 167 | Agnosia (HP:0010524) | 1.75635794 |
| 168 | Xerostomia (HP:0000217) | 1.75166515 |
| 169 | Curly hair (HP:0002212) | 1.75006584 |
| 170 | Abnormal hand bone ossification (HP:0010660) | 1.74011576 |
| 171 | Neoplasm of head and neck (HP:0012288) | 1.73437603 |
| 172 | Esophageal neoplasm (HP:0100751) | 1.73437603 |
| 173 | Urticaria (HP:0001025) | 1.73432897 |
| 174 | Progressive visual loss (HP:0000529) | 1.72374907 |
| 175 | Aortic dissection (HP:0002647) | 1.70341908 |
| 176 | Recurrent cutaneous fungal infections (HP:0011370) | 1.68912994 |
| 177 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.68912994 |
| 178 | Inflammation of the large intestine (HP:0002037) | 1.68373553 |
| 179 | Osteolytic defects of the hand bones (HP:0009699) | 1.65619491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 4.30525745 |
| 2 | LIMK1 | 3.58971515 |
| 3 | TAOK1 | 3.15386972 |
| 4 | PIK3CA | 2.98126061 |
| 5 | LMTK2 | 2.95685500 |
| 6 | ARAF | 2.88280341 |
| 7 | IKBKE | 2.75400463 |
| 8 | KSR2 | 2.61473208 |
| 9 | MST1R | 2.55243759 |
| 10 | MST4 | 2.54330556 |
| 11 | EPHA2 | 2.45155213 |
| 12 | PBK | 2.38112738 |
| 13 | EIF2AK1 | 2.35411486 |
| 14 | RIPK1 | 2.22932648 |
| 15 | BUB1 | 2.19989332 |
| 16 | VRK2 | 2.17492474 |
| 17 | MAP3K14 | 2.00918704 |
| 18 | MAP2K2 | 1.87887515 |
| 19 | MAP3K9 | 1.84375005 |
| 20 | PIM2 | 1.84292502 |
| 21 | FRK | 1.82405296 |
| 22 | STK10 | 1.81272256 |
| 23 | DDR2 | 1.78680161 |
| 24 | PDK2 | 1.72765491 |
| 25 | TAOK3 | 1.65136624 |
| 26 | PRKG2 | 1.58576393 |
| 27 | RIPK4 | 1.56389259 |
| 28 | ERN1 | 1.55974943 |
| 29 | MAP3K11 | 1.53973667 |
| 30 | TYK2 | 1.53844141 |
| 31 | MOS | 1.53519099 |
| 32 | TESK1 | 1.47850840 |
| 33 | IKBKB | 1.47410622 |
| 34 | NEK1 | 1.43209772 |
| 35 | TGFBR2 | 1.36681101 |
| 36 | TTK | 1.34087282 |
| 37 | MAP3K8 | 1.29890991 |
| 38 | EPHB2 | 1.28393935 |
| 39 | MAP3K13 | 1.25969736 |
| 40 | MAPKAPK3 | 1.22798743 |
| 41 | MAP3K3 | 1.19693611 |
| 42 | RAF1 | 1.19509228 |
| 43 | BRAF | 1.19243768 |
| 44 | ERBB4 | 1.10167664 |
| 45 | NEK9 | 1.06127456 |
| 46 | ACVR1B | 1.05667405 |
| 47 | STK38L | 1.05322222 |
| 48 | ABL2 | 1.00288926 |
| 49 | NME1 | 0.99085338 |
| 50 | MYLK | 0.97793973 |
| 51 | TTN | 0.93781593 |
| 52 | KDR | 0.92506766 |
| 53 | GRK6 | 0.91268506 |
| 54 | KIT | 0.90456651 |
| 55 | TAOK2 | 0.89811553 |
| 56 | BCKDK | 0.88202360 |
| 57 | CHUK | 0.87464427 |
| 58 | STK3 | 0.86024972 |
| 59 | MAP2K6 | 0.85843033 |
| 60 | MUSK | 0.85479270 |
| 61 | DAPK1 | 0.85059313 |
| 62 | DMPK | 0.83337241 |
| 63 | IRAK3 | 0.82979999 |
| 64 | RPS6KA4 | 0.81498308 |
| 65 | BMPR2 | 0.81386135 |
| 66 | MELK | 0.80802543 |
| 67 | STK16 | 0.79889770 |
| 68 | LATS1 | 0.79453201 |
| 69 | FER | 0.77684568 |
| 70 | MAP2K3 | 0.76559594 |
| 71 | MAP2K1 | 0.75728420 |
| 72 | TRIM28 | 0.75322395 |
| 73 | PTK2 | 0.74713715 |
| 74 | TRPM7 | 0.74654196 |
| 75 | ILK | 0.73722090 |
| 76 | TESK2 | 0.72281685 |
| 77 | BLK | 0.70384359 |
| 78 | MAP3K1 | 0.69130798 |
| 79 | SIK3 | 0.68979850 |
| 80 | NME2 | 0.67294131 |
| 81 | PKN2 | 0.64139191 |
| 82 | CSK | 0.63953443 |
| 83 | TLK1 | 0.63723570 |
| 84 | MAP3K2 | 0.62743771 |
| 85 | STK39 | 0.62509474 |
| 86 | JAK1 | 0.61578459 |
| 87 | PIM1 | 0.60271303 |
| 88 | PDPK1 | 0.59940402 |
| 89 | MAP3K5 | 0.59511398 |
| 90 | MAP4K1 | 0.58575928 |
| 91 | AURKB | 0.56696629 |
| 92 | BRSK1 | 0.56564365 |
| 93 | PDGFRA | 0.56203339 |
| 94 | MATK | 0.54877366 |
| 95 | PTK6 | 0.54310174 |
| 96 | STK38 | 0.52245597 |
| 97 | CAMK2D | 0.52067070 |
| 98 | GSK3A | 0.49205022 |
| 99 | PRKCI | 0.48794206 |
| 100 | AURKA | 0.48657358 |
| 101 | KSR1 | 0.48556827 |
| 102 | IRAK4 | 0.47764614 |
| 103 | PTK2B | 0.47672144 |
| 104 | BCR | 0.47598349 |
| 105 | SCYL2 | 0.46918718 |
| 106 | MAPKAPK2 | 0.46860003 |
| 107 | JAK3 | 0.46575344 |
| 108 | CDK8 | 0.46467125 |
| 109 | PAK4 | 0.45215268 |
| 110 | MET | 0.43887482 |
| 111 | ROCK1 | 0.43866504 |
| 112 | PAK1 | 0.43002721 |
| 113 | TXK | 0.42759067 |
| 114 | MAP3K12 | 0.42284353 |
| 115 | PHKG1 | 0.40986347 |
| 116 | PHKG2 | 0.40986347 |
| 117 | DAPK3 | 0.40832369 |
| 118 | LRRK2 | 0.40740949 |
| 119 | ERBB3 | 0.40501442 |
| 120 | LYN | 0.40036457 |
| 121 | NLK | 0.39988377 |
| 122 | EPHB1 | 0.39741321 |
| 123 | CDK9 | 0.39492710 |
| 124 | HCK | 0.38753732 |
| 125 | BMX | 0.38506886 |
| 126 | FGR | 0.38262604 |
| 127 | ROCK2 | 0.38096723 |
| 128 | OXSR1 | 0.37929246 |
| 129 | MAPKAPK5 | 0.36976558 |
| 130 | PRKCD | 0.36922584 |
| 131 | TRIB3 | 0.36780392 |
| 132 | ABL1 | 0.36739159 |
| 133 | VRK1 | 0.36325853 |
| 134 | GRK5 | 0.35764089 |
| 135 | ADRBK1 | 0.35736204 |
| 136 | NUAK1 | 0.35530634 |
| 137 | NEK6 | 0.33592438 |
| 138 | NTRK1 | 0.33341297 |
| 139 | MAP3K6 | 0.33339615 |
| 140 | CAMK2G | 0.33332513 |
| 141 | PLK1 | 0.32433424 |
| 142 | CDK7 | 0.31875944 |
| 143 | ZAP70 | 0.31268512 |
| 144 | STK24 | 0.29240517 |
| 145 | FLT3 | 0.27244011 |
| 146 | MAPK11 | 0.27222946 |
| 147 | CDK14 | 0.23978648 |
| 148 | PRKD2 | 0.22878765 |
| 149 | CSNK1G3 | 0.22818333 |
| 150 | CDK18 | 0.22764722 |
| 151 | SRC | 0.21945326 |
| 152 | GRK7 | 0.21748870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.81946526 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.18743409 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.03846857 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80628457 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.79700321 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.67388843 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.67072860 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.65104149 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.57657192 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.50389874 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.38021317 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.19157142 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 2.16246445 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06513874 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 2.04887214 |
| 16 | Hepatitis C_Homo sapiens_hsa05160 | 1.93010073 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92410950 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92324175 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91105313 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.89395382 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.88199715 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.79779373 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77664708 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77296546 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.69434818 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.68583466 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67609620 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.59624651 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57587779 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.50395348 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.50053260 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49428236 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48428768 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47211325 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47107737 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45113743 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41212321 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41174043 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38103141 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37975581 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37208044 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.37059386 |
| 43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.36818154 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35163035 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.32422496 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30902033 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26629237 |
| 48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.25178588 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23528604 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22495838 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22108870 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17106253 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17022382 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15673926 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.14575458 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13599981 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12075870 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12017005 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09157133 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08896018 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.06777630 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 1.06604375 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05926028 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 1.04061158 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.02122020 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01933807 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99412800 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98826331 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.96804172 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95723519 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95093844 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93831396 |
| 73 | Hepatitis B_Homo sapiens_hsa05161 | 0.93741230 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.86444275 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86360440 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86292104 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84195618 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84139361 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81963665 |
| 80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79678965 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.79387912 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78512262 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78010388 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77507358 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76345360 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76306731 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75789369 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72471688 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71799061 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70856090 |
| 91 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70413366 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67799616 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66408798 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65960161 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.65544212 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65196159 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64939617 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.64859575 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64828354 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62857469 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61589684 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61462386 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61080275 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59571327 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59181523 |
| 106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58712861 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57398932 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56725153 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56204951 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.56163090 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55968082 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55896173 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55658805 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55658042 |
| 115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55555564 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53003392 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52523896 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.52254750 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.48895517 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48304683 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47914838 |
| 122 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47410379 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47233928 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.46483260 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46453342 |
| 126 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45612081 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44324935 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44185920 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43537438 |
| 130 | Mismatch repair_Homo sapiens_hsa03430 | 0.43457785 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41078040 |
| 132 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40968997 |
| 133 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40901662 |
| 134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39996424 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39767266 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39162395 |
| 137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38952354 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38801286 |
| 139 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38609497 |
| 140 | RNA polymerase_Homo sapiens_hsa03020 | 0.38575068 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38447248 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38256130 |
| 143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38108634 |
| 144 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37796849 |
| 145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37277140 |
| 146 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37057309 |
| 147 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33613895 |
| 148 | Peroxisome_Homo sapiens_hsa04146 | 0.32129356 |
| 149 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32049584 |
| 150 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31978295 |
| 151 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31480968 |
| 152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30923721 |

